Association of maternal immunity with rotavirus vaccine immunogenicity in Zambian Infants

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Chilengi, Roma ^a,b   Simuyandi, Michelo ^a   Beach, Lauren ^a   Mwila, Katayi ^a   Becker Dreps, Sylvia ^b   Emperador, Devy M ^c   Velasquez, Daniel E ^c   Bosomprah, Samuel ^a   Jiang, Baoming ^c  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; BREAST MILK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ROTAVIRUS INFECTION; SEASONAL VARIATION; SEROCONVERSION; VACCINATION; ZAMBIAN; BLOOD; BREAST FEEDING; CLINICAL TRIAL; IMMUNOLOGY; MULTICENTER STUDY; NEWBORN; ZAMBIA;

ANTIBODIES, VIRAL; BREAST FEEDING; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; ZAMBIA;

EID: 84961755389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150100     Document Type: Article

References (46)

1. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82: 285-96. PMID: 17691162
2. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200:Suppl 1:S9-S15. doi: 10.1086/605025 PMID: 19817620
3. Parashar UD, Gibson CJ, Bresse J.S., Glass RI. Rotavirus and severe childhood diarrhoea. Emerg Infect Dis 2006; 12: 304-6. PMID: 16494759
4. Patel M, Shane AL, Parashar U.D., Jiang B., Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009; 200 Suppl 1:S39-48. Epub 2009/10/13. doi:10.1086/605035 PMID: 19817613.
5. Jiang V, Jiang B, Tate J., Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin. 2010; 6(7):532-42. Epub 2010/07/14.11278 [pii]. PMID: 20622508.
6. WHO. World Health Organization. Introduction: of rotavirus vaccines into national immunization programmemes. Geneva., 2009.
7. WHO. WHO Strategic Advisory Group of Experts (SAGE) on Immunisation. Weekly epidemiological record. 2009; 84th year June (23): 213-236.
8. Glaxo Smith Kline. RotaRix Prescribing Information. Accessed 30th May 2011 at http://us.gsk.com/products/assets/usrotarix.pdf
9. Ruiz-Palacios G.M., Perez-Schael I, Velazquez F.R., Abate H., Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354(1): 11-22. PMID: 16394298
10. Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371(9619): 1181-9. doi: 10.1016/S0140-6736(08)60524-3 PMID: 18395579
11. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370(9601): 1757-63. PMID: 18037080
12. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354(1): 23-33. PMID: 16394299
13. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B., Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhoea in Mexico. N Engl J Med 2010; 362(4): 299-305. doi: 10.1056/NEJMoa0905211 PMID: 20107215
14. Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J Infect Dis 2005; 192 Suppl 1: S160-6. PMID: 16088799
15. Patel M, Shane AL, Parashar U.D., Jiang B., Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200 Suppl 1): S39-48. doi: 10.1086/605035 PMID: 19817613
16. Madhi SA, Cunliffe NA, Steele D, Witte D., Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhoea in African infants. N Engl J Med 2010; 362(4):289-98. doi: 10.1056/NEJMoa0904797 PMID: 20107214
17. Chan J, Nirwati H, Triasih R., Bogdanovic-Sakran N, Soenarto Y, Hakimi M., et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine 2011; 29(6): 1242-7. doi: 10.1016/j.vaccine.2010.11.087 PMID: 21147127
18. Kvistgaard AS, Pallesen LT, Arias C.F., Lopez S., Petersen TE, Heegaard CW, et al. Inhibitory effects of human and bovine milk constituents on rotavirus infections. J Dairy Sci. 2004; 87(12):4088-96. PMID: 15545370
19. Glass RI, Stoll BJ The protective effect of human milk against diarrhea. A review of studies from Bangladesh. Acta Paediatr Sc and Suppl. 1989; 351:131-6. Epub 1989/01/01. PMID: 2692384.
20. Jiang B, Gentsch JR, Glass RI The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis 2002; 34(10):1351-61. PMID: 11981731
21. Moon SS, Wang Y, Shane A.L., Nguyen T., Ray P, Dennehy P, et al Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J. 2010; 29(10):919-23. doi: 10.1097/INF.0b013e3181e232ea PMID: 20442687
22. Becker-Dreps S., Vilchez S, Velasquez D., Moon SS, Hudgens MG, Zambrana LE, et al Rotavirus-specific IgG antibodies from mothers' serum may inhibit immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J, 2015; 34(1):115-116.) doi: 10.1097/INF.0000000000000481 PMID: 25741808
23. Moon SS, Tate JE, Ray P, Dennehy P.H., Archary D., Coutsoudis A, et al. Differential profiles and inhibitory effect on rotavirus vaccines of non-antibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J. 2013; 32(8):863-70. doi: 10.1097/INF.0b013e318290646d PMID: 23584581
24. Mwenda J.M, Ntoto K.N, Abebe A, Enweronu-Laryea C, Amina I, Mchomvu J et al. Burden and Epidemiology of Rotavirus Diarrhea in Selected African Countries: Preliminary Results: from the African Rotavirus Surveillance Network. J. Infect. Dis 2010; 202(S1):S5-S11
25. Mpabalwani M, Oshitani H, Kasolo F., Mizuta K, Luo N, Matsubayashi N et al. Rotavirus gastro-enteritis in hospitalized children with acute diarrhoea in Zambia. Ann Trop Paediatr. 1995; 15:39-43. PMID: 7598436
26. Cunliffe N.A, Kilgore P.E, Bresee J.S, Steele D.A, Luo N, et a.l., Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ. 1998; 76(5): 525-537. PMID: 9868844
27. Groome MJ, Moon SS, Velasquez D, Jones S., Koen A, van Niekerk N, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014; 92(4):238-45. Epub 2014/04/05. doi:10.2471/BLT.13.128066 BLT.13.128066 [pii]. PMID: 24700991.
28. Waggie Z, Hawkridge A, and Hussey GD. Review of Rotavirus Studies in Africa: 1976-2006. JID 2010: 202 (Suppl 1). S23
29. Parashar UD, Hummelman EG, Bresee J.S., Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9(5):565-572. PMID: 12737740
30. WHO. Global networks for surveillance of rotavirus gastroenteritis, 2001-2008. Wkly EpidemiolRec 2008; 83:421-428. PMID: 19024780
31. Moon S, Wang Y, Shane A. Let al. Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines. Pediatr Infect Dis J. 2010 October; 29(10): 919-923. doi: 10.1097/INF.0b013e3181e232ea PMID: 20442687
32. Ali A, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, et al. (2015) Impact of Withholding Breastfeeding at the Time of Vaccination on the Immunogenicity of Oral Rotavirus Vaccine - A Randomized Trial. PLoSONE 10(6): e0127622. doi: 10.1371/journal.pone.0127622 PMID: 26035743
33. Rongsen-Chandolaa T, Strand T.A, Goyala N, Flemd E, Rathorea S. S et al. Effect of withholding breastfeeding on the immune response to a liveoral rotavirus vaccine in North Indian infants. Vaccine, 32S (2014) A134-A139
34. Xu J, Dennehy P, Keyserling H., Westerman L.E, Wang Y et al. Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection. Clinical and diagnostic laboratory Immunology, 2005, p. 273-279 Vol. 12, No. 2.
35. Clemens J. D, Ward R.L, Rao M.R, Sack D.A, Knowlton D.R, et al. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. (1992) 165:161-165. PMID: 1309372
36. O'Ryan M. L., Matson D.O, Estes M.K, Pickering L.K. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J. Infect. Dis. (1994) 169:504-511. PMID: 8158022
37. Ray P. G, Kelkar S.D. Measurement of antirotavirus IgM/IgA/IgG responses in the serum samples of Indian children following rotavirus diarrhea and their mothers. J. Med. Virol. (2004) 72:416-423. PMID: 14748065
38. Velazquez FR, Matson DO, Guerrero M.L., Shults J., Calva JJ, Morrow AL, et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis 2000; 182(6): 1602-9. PMID: 11069230
39. O'Ryan M.L., Matson DO, Estes M.K., Pickering LK. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections. J Infect Dis 1994; 169(3): 504-11. PMID: 8158022
40. Dennehy PH, Rodgers GC Jr., Ward R.L., Markwick AJ, Mack M, Zito ET. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group. Pediatr Infect Dis J 1996; 15(11): 1012-8. PMID: 8933551
41. Appaiahgari MB, Glass R, Singh S., Taneja S, Rongsen-Chandola T, Bhandari N, Mishra S, Vrati S (2014). Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116Ein Indian infants. Vaccine 3; 32(6):651-6. doi: 10.1016/j.vaccine.2013.12.017 PMID: 24374502
42. Moon SS, Groome MJ, Velasquez DE, Parashar UD, Jones S et al. Prevaccination rotavirus serum IgG and IgA are associated with lower immunogenicity of live, oral human rotavirus vaccine in South African infants. Clin Infect Dis, 2016. 62(2): p. 157-65. doi: 10.1093/cid/civ828 PMID: 26400993
43. Humphrey JH. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009; 374: 9694
44. Campbel DI, Simon HM, Elia M, Sullivan PB, Sanyang MS, Jobarteh B, Lunn PG. ChronicT Cell-Mediated Enteropathy in Rural West African Children: Relationship with Nutritional Status and Small Bowel Function. Paediatric Research 2003; Vol. 54, No. 3
45. Wood D, WHO IC Group (2005). WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines. Mexico City, Mexico, 8-9 February 2005. Vaccine, 23(48-49):5478-5487. PMID: 16129525
46. Maier EA, Weage KJ, Guedes M.M., Denson LA, McNeal MM, Bernstein DI et al. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice Vaccine. 2013; 32(1):48-53. doi: 10.1016/j.vaccine.2013.10.072 PMID: 24200975